Elos Medtech AB (publ)

OM:ELOS B Stock Report

Market Cap: SEK 5.7b

Elos Medtech Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Elos Medtech.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth36.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)

Oct 11
Calculating The Fair Value Of Elos Medtech AB (publ) (STO:ELOS B)

Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?

May 23
Is Now The Time To Look At Buying Elos Medtech AB (publ) (STO:ELOS B)?

Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock

May 10
Here's Why I Think Elos Medtech (STO:ELOS B) Is An Interesting Stock

Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)

Apr 17
Returns On Capital Are Showing Encouraging Signs At Elos Medtech (STO:ELOS B)

We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt

Mar 24
We Think Elos Medtech (STO:ELOS B) Is Taking Some Risk With Its Debt

Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?

Mar 11
Should Elos Medtech AB (publ) (STO:ELOS B) Be Part Of Your Dividend Portfolio?

The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares

Feb 28
The President & CEO of Elos Medtech AB (publ) (STO:ELOS B), Jan Wahlström, Just Bought 28% More Shares

Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?

Feb 24
Do Fundamentals Have Any Role To Play In Driving Elos Medtech AB (publ)'s (STO:ELOS B) Stock Up Recently?

Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment

Feb 11
Elos Medtech (STO:ELOS B) Has Gifted Shareholders With A Fantastic 102% Total Return On Their Investment

When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?

Jan 31
When Should You Buy Elos Medtech AB (publ) (STO:ELOS B)?

How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?

Jan 18
How Much Are Elos Medtech AB (publ) (STO:ELOS B) Insiders Taking Off The Table?

Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture

Jan 06
Returns On Capital At Elos Medtech (STO:ELOS B) Paint An Interesting Picture

Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?

Dec 26
Could The Elos Medtech AB (publ) (STO:ELOS B) Ownership Structure Tell Us Something Useful?

Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Dec 13
Elos Medtech (STO:ELOS B) Has A Somewhat Strained Balance Sheet

Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential

Nov 30
Here's Why We Don't Think Elos Medtech's (STO:ELOS B) Statutory Earnings Reflect Its Underlying Earnings Potential

Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Nov 17
Elos Medtech AB (publ)'s (STO:ELOS B) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Elos Medtech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OM:ELOS B - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20231,01855-5295N/A
6/30/202399855-1121N/A
3/31/202396176-7113N/A
12/31/202288975-9108N/A
9/30/2022843947123N/A
6/30/202279990-1781N/A
3/31/2022747791189N/A
12/31/20217247619105N/A
9/30/2021694671496N/A
6/30/20216556245125N/A
3/31/20215925155141N/A
12/31/20205803669126N/A
9/30/20205843374116N/A
6/30/20205932943105N/A
3/31/20206582920102N/A
12/31/2019689394102N/A
9/30/201970035-4107N/A
6/30/201969732-1295N/A
3/31/201967929-2167N/A
12/31/201864521-1466N/A
9/30/201862524-1266N/A
6/30/201860321058N/A
3/31/2018593231259N/A
12/31/2017578232562N/A
9/30/2017562184068N/A
6/30/201755623N/A86N/A
3/31/201755229N/A90N/A
12/31/201655226N/A98N/A
9/30/201655527N/A95N/A
6/30/201655120N/A74N/A
3/31/201653915N/A71N/A
12/31/201550416N/A63N/A
9/30/201547417N/A120N/A
6/30/201543623N/A181N/A
3/31/201539826N/A196N/A
12/31/201438123N/A175N/A
9/30/201437125N/A120N/A
6/30/201436918N/A94N/A
3/31/201436617N/A75N/A
12/31/201336817N/A80N/A
9/30/201339620N/A82N/A
6/30/201341318N/A51N/A
3/31/201342412N/A46N/A
12/31/20124348N/A39N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ELOS B's forecast earnings growth is above the savings rate (0.8%).

Earnings vs Market: Insufficient data to determine if ELOS B's earnings are forecast to grow faster than the Swedish market

High Growth Earnings: Insufficient data to determine if ELOS B's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if ELOS B's revenue is forecast to grow faster than the Swedish market.

High Growth Revenue: Insufficient data to determine if ELOS B's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ELOS B's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/12/21 10:06
End of Day Share Price 2023/12/19 00:00
Earnings2023/09/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Elos Medtech AB (publ) is covered by 2 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Oskar VikströmABG Sundal Collier Sponsored
Andreas KvistRedeye